Zacks Research Estimates Revvity’s Q4 Earnings (NYSE:RVTY)

Revvity, Inc. (NYSE:RVTY) – Equities researchers at Zacks Research lowered their Q4 2025 earnings per share estimates for Revvity in a research report issued on Monday, April 14th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $1.49 per share for the quarter, down from their prior estimate of $1.50. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity’s Q3 2026 earnings at $1.44 EPS and Q4 2026 earnings at $1.56 EPS.

Revvity (NYSE:RVTY) last released its earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the prior year, the firm posted $1.25 EPS.

Other research analysts have also issued research reports about the company. Sanford C. Bernstein lowered Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target on the stock. in a report on Friday, January 10th. Raymond James reaffirmed an “outperform” rating and issued a $145.00 price objective (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Barclays dropped their price target on shares of Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a research report on Thursday, April 10th. Wells Fargo & Company dropped their target price on Revvity from $130.00 to $102.00 and set an “equal weight” rating on the stock in a report on Thursday. Finally, KeyCorp raised their price objective on Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $131.42.

Revvity Price Performance

RVTY stock opened at $91.82 on Thursday. Revvity has a 1 year low of $89.61 and a 1 year high of $129.50. The stock has a market capitalization of $11.03 billion, a PE ratio of 41.55, a price-to-earnings-growth ratio of 3.82 and a beta of 1.07. The company’s 50-day moving average is $107.18 and its 200-day moving average is $114.37. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s payout ratio is 12.67%.

Insider Activity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the transaction, the insider now directly owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.68% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Assetmark Inc. boosted its position in Revvity by 3,700.0% during the fourth quarter. Assetmark Inc. now owns 266 shares of the company’s stock worth $30,000 after purchasing an additional 259 shares during the period. Optiver Holding B.V. bought a new stake in Revvity during the 4th quarter valued at $33,000. Quarry LP boosted its holdings in shares of Revvity by 45.7% in the fourth quarter. Quarry LP now owns 303 shares of the company’s stock worth $34,000 after acquiring an additional 95 shares during the period. Millstone Evans Group LLC bought a new stake in shares of Revvity during the 4th quarter valued at $38,000. Finally, Vermillion Wealth Management Inc. bought a new position in Revvity in the 4th quarter worth about $41,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.